electroCore, Inc. (ECOR)

Market Cap	33.91M
Revenue (ttm)	16.03M
Net Income (ttm)	-18.83M
Shares Out	6.00M
EPS (ttm)	-3.42
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,557
Open	5.58
Previous Close	5.58
Day's Range	5.41 - 5.88
52-Week Range	3.83 - 8.08
Beta	0.93
Analysts	Strong Buy
Price Target	15.00 (+165.49%)
Earnings Date	May 10, 2024

About ECOR

electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general healt...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jun 22, 2018
• Employees: 68
• Stock Exchange: NASDAQ
• Ticker Symbol: ECOR

Financial Performance

In 2023, electroCore's revenue was $16.03 million, an increase of 86.57% compared to the previous year's $8.59 million. Losses were -$18.83 million, -15.02% less than in 2022.

Analyst Forecast

According to one analyst, the rating for ECOR stock is "Strong Buy" and the 12-month stock price forecast is $15.0.

Price Target

$15.0

(165.49% upside)

Analyst Consensus: Strong Buy